SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001144204-19-040337
Filing Date
2019-08-16
Accepted
2019-08-16 09:30:47
Documents
2
Group Members
CALC III LPCITADEL ADVISORS HOLDINGS LPCITADEL GP LLCCITADEL SECURITIES GP LLCCITADEL SECURITIES LLCKENNETH GRIFFIN

Document Format Files

Seq Description Document Type Size
1 SC 13G tv527767_sc13g.htm SC 13G 171603
2 EXHIBIT 99.1 tv527767_ex99-1.htm EX-99.1 10300
  Complete submission text file 0001144204-19-040337.txt   183608
Mailing Address 131 S. DEARBORN ST., 32ND FLOOR CHICAGO IL 60603
Business Address 131 S. DEARBORN ST., 32ND FLOOR CHICAGO IL 60603 312-395-2100
CITADEL ADVISORS LLC (Filed by) CIK: 0001423053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Subject) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86488 | Film No.: 191031689
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences